Implantable Drug Eluting Stent Market - Global Forecast 2026-2032

The implantable drug eluting stent market is evolving rapidly as clinical expectations intersect with operational demands and regulatory scrutiny, driving a new era of platform innovation, supply resilience, and value-oriented decision-making. Senior stakeholders need actionable, data-driven insights to navigate an increasingly complex and segmented landscape.

Market Snapshot: Implantable Drug Eluting Stent Market Overview

The Implantable Drug Eluting Stent Market expanded from USD 3.77 billion in 2025 to USD 4.05 billion in 2026 and is primed to maintain strong growth at a CAGR of 8.53%, reaching USD 6.69 billion by 2032. This momentum reflects increasing clinical adoption, greater emphasis on value-based procurement, and broadened use in coronary and peripheral interventions. Market growth is bolstered by the rising prevalence of complex vessel disease cases and progressive improvements in device design and drug release profiles.

Scope & Segmentation of the Implantable Drug Eluting Stent Market

This report provides strategic segmentation and detailed analysis of the following dimensions:

Stent Types: Covers both coronary and peripheral drug eluting stents, revealing differing clinical priorities and adoption drivers.
Material Types: Insights include platforms such as cobalt chromium, platinum chromium, stainless steel, and nitinol, each influencing performance, cost efficiency, and design flexibility.
Drug Types: Evaluates key drugs including sirolimus, everolimus, paclitaxel, and zotarolimus, considering effectiveness, risk profile, and relevance to specific patient groups.
Polymer Approaches: Analysis spans durable polymers, bioresorbable polymers, and polymer-free alternatives, reflecting changing clinical and regulatory preferences.
Distribution Channels: Assesses the role of hospitals, ambulatory surgical centers, direct tenders, and third-party distributors in influencing purchasing breadth and channel dynamics.
Geographical Regions: Focuses on the Americas, EMEA, and Asia-Pacific, with attention to reimbursement structures, procurement models, and regional regulatory environments.
Technology Trends: Explores advancements in strut design, polymer science, drug delivery, and digitalization of cath lab workflows.

Key Takeaways: Strategic Insights for Senior Decision-Makers

Clinical selection criteria now center on proven real-world performance, long-term safety, and procedural efficiency, particularly for complex and high-risk patient profiles.
Innovation is integrating design, pharmacology, and clinical workflow considerations to optimize healing profiles, minimize follow-up requirements, and enable flexible antiplatelet regimens.
Procurement decisions are influenced by supply chain reliability, regulatory compliance, and the ability to prove consistent manufacturing quality across product lots.
Manufacturers are challenged to convert engineering improvements into credible, evidence-backed narratives supporting both clinical and economic value propositions.
Competition is intensifying in regions prioritizing scalable solutions, agile contracting, and responsive service—requiring tailored approaches to both established and emerging markets.

Tariff Impact: Implications for Cost, Sourcing, and Validation Cycles

Anticipated tariff changes in 2025 are expected to influence the implantable drug eluting stent market by affecting sourcing strategies and raising the need for validation cycles for components and materials. This dynamic may drive companies towards further diversification of supply chains, dual sourcing, and increased attention to contract structure. While price predictability remains a priority for hospitals and group purchasing organizations, manufacturers must manage cost pressures without disrupting clinical supply or product quality. The net effect escalates the role of cost engineering and collaborative supplier management throughout the value chain.

Methodology & Data Sources

Our analysis combines comprehensive secondary research on clinical, regulatory, and technological trends with primary interviews involving clinicians, supply chain managers, and industry executives. Validation is performed through cross-referencing stakeholder insights with public documentation, regulatory filings, and clinical evidence, ensuring a robust and transparent foundation for decision-making.

Why This Report Matters

Empowers procurement, strategy, and product development leaders with actionable intelligence tailored to shifting regulatory and operational realities.
Enables evidence-based evaluation and benchmarking of stent technologies, manufacturing approaches, and commercial models across diverse healthcare environments.
Supports risk mitigation amid supply chain volatility and evolving reimbursement requirements, helping organizations align portfolios with emerging market needs.

Conclusion

The implantable drug eluting stent market favors platforms combining trusted clinical performance, operational dependability, and adaptable regional strategies. Organizations aligning innovation, evidence, and execution will be positioned to sustain trust and outperform in a demanding environment.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Implantable Drug Eluting Stent Market, by Stent Generation

8.1. First Generation
8.2. Second Generation
8.3. Third Generation

9. Implantable Drug Eluting Stent Market, by Polymer Coating

9.1. Bioabsorbable Polymer
9.1.1. Poly-L-Lactic Acid
9.1.2. Polyglycolic Acid
9.2. Durable Polymer
9.3. Polymer Free

10. Implantable Drug Eluting Stent Market, by Drug Coating

10.1. Everolimus
10.2. Paclitaxel
10.3. Sirolimus
10.4. Zotarolimus

11. Implantable Drug Eluting Stent Market, by End User

11.1. Ambulatory Surgery Centers
11.2. Cardiac Catheterization Laboratories
11.3. Hospitals
11.3.1. Private Hospitals
11.3.2. Public Hospitals

12. Implantable Drug Eluting Stent Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Implantable Drug Eluting Stent Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Implantable Drug Eluting Stent Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Implantable Drug Eluting Stent Market
16. China Implantable Drug Eluting Stent Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Alvimedica Medical Technologies Inc.
17.7. B. Braun Melsungen AG
17.8. Balton Sp. z o.o.
17.9. Biosensors International Group, Ltd.
17.10. BIOTRONIK SE & Co. KG
17.11. Boston Scientific Corporation
17.12. Concept Medical, Inc.
17.13. Cook Medical Incorporated
17.14. Elixir Medical Corporation
17.15. Eucatech AG
17.16. Eurocor GmbH
17.17. iVascular S.L.U.
17.18. Lepu Medical Technology (Beijing) Co., Ltd.
17.19. Medinol Ltd.
17.20. Medtronic plc
17.21. Meril Life Sciences Pvt. Ltd.
17.22. OrbusNeich Medical Group
17.23. Sahajanand Medical Technologies Ltd.
17.24. Terumo Corporation

List of Figures

FIGURE 1. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY STENT GENERATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY STENT GENERATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY FIRST GENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY FIRST GENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY FIRST GENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY SECOND GENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY SECOND GENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY SECOND GENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY THIRD GENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY THIRD GENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY THIRD GENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATING, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLY-L-LACTIC ACID, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLY-L-LACTIC ACID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLY-L-LACTIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DURABLE POLYMER, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DURABLE POLYMER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DURABLE POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER FREE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY EVEROLIMUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY EVEROLIMUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY EVEROLIMUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY PACLITAXEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY PACLITAXEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY PACLITAXEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY SIROLIMUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY SIROLIMUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY SIROLIMUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY ZOTAROLIMUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY ZOTAROLIMUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY ZOTAROLIMUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY CARDIAC CATHETERIZATION LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. AMERICAS IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 61. AMERICAS IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY STENT GENERATION, 2018-2032 (USD MILLION)
TABLE 62. AMERICAS IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATING, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2032 (USD MILLION)
TABLE 65. AMERICAS IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 66. AMERICAS IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. NORTH AMERICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY STENT GENERATION, 2018-2032 (USD MILLION)
TABLE 69. NORTH AMERICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATING, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. LATIN AMERICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY STENT GENERATION, 2018-2032 (USD MILLION)
TABLE 76. LATIN AMERICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATING, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY STENT GENERATION, 2018-2032 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATING, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2032 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 88. EUROPE IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. EUROPE IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY STENT GENERATION, 2018-2032 (USD MILLION)
TABLE 90. EUROPE IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATING, 2018-2032 (USD MILLION)
TABLE 91. EUROPE IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, 2018-2032 (USD MILLION)
TABLE 92. EUROPE IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2032 (USD MILLION)
TABLE 93. EUROPE IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 94. EUROPE IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. MIDDLE EAST IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY STENT GENERATION, 2018-2032 (USD MILLION)
TABLE 97. MIDDLE EAST IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATING, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, 2018-2032 (USD MILLION)
TABLE 99. MIDDLE EAST IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2032 (USD MILLION)
TABLE 100. MIDDLE EAST IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 102. AFRICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. AFRICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY STENT GENERATION, 2018-2032 (USD MILLION)
TABLE 104. AFRICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATING, 2018-2032 (USD MILLION)
TABLE 105. AFRICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, 2018-2032 (USD MILLION)
TABLE 106. AFRICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2032 (USD MILLION)
TABLE 107. AFRICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 108. AFRICA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY STENT GENERATION, 2018-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATING, 2018-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, 2018-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. ASEAN IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. ASEAN IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY STENT GENERATION, 2018-2032 (USD MILLION)
TABLE 119. ASEAN IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATING, 2018-2032 (USD MILLION)
TABLE 120. ASEAN IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, 2018-2032 (USD MILLION)
TABLE 121. ASEAN IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2032 (USD MILLION)
TABLE 122. ASEAN IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 123. ASEAN IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 124. GCC IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GCC IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY STENT GENERATION, 2018-2032 (USD MILLION)
TABLE 126. GCC IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATING, 2018-2032 (USD MILLION)
TABLE 127. GCC IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, 2018-2032 (USD MILLION)
TABLE 128. GCC IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2032 (USD MILLION)
TABLE 129. GCC IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. GCC IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 131. EUROPEAN UNION IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. EUROPEAN UNION IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY STENT GENERATION, 2018-2032 (USD MILLION)
TABLE 133. EUROPEAN UNION IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATING, 2018-2032 (USD MILLION)
TABLE 134. EUROPEAN UNION IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, 2018-2032 (USD MILLION)
TABLE 135. EUROPEAN UNION IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2032 (USD MILLION)
TABLE 136. EUROPEAN UNION IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. EUROPEAN UNION IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 138. BRICS IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. BRICS IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY STENT GENERATION, 2018-2032 (USD MILLION)
TABLE 140. BRICS IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATING, 2018-2032 (USD MILLION)
TABLE 141. BRICS IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, 2018-2032 (USD MILLION)
TABLE 142. BRICS IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2032 (USD MILLION)
TABLE 143. BRICS IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. BRICS IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 145. G7 IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. G7 IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY STENT GENERATION, 2018-2032 (USD MILLION)
TABLE 147. G7 IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATING, 2018-2032 (USD MILLION)
TABLE 148. G7 IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, 2018-2032 (USD MILLION)
TABLE 149. G7 IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2032 (USD MILLION)
TABLE 150. G7 IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. G7 IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 152. NATO IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. NATO IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY STENT GENERATION, 2018-2032 (USD MILLION)
TABLE 154. NATO IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATING, 2018-2032 (USD MILLION)
TABLE 155. NATO IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, 2018-2032 (USD MILLION)
TABLE 156. NATO IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2032 (USD MILLION)
TABLE 157. NATO IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. NATO IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. UNITED STATES IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 161. UNITED STATES IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY STENT GENERATION, 2018-2032 (USD MILLION)
TABLE 162. UNITED STATES IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATING, 2018-2032 (USD MILLION)
TABLE 163. UNITED STATES IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, 2018-2032 (USD MILLION)
TABLE 164. UNITED STATES IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2032 (USD MILLION)
TABLE 165. UNITED STATES IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. UNITED STATES IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 167. CHINA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 168. CHINA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY STENT GENERATION, 2018-2032 (USD MILLION)
TABLE 169. CHINA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATING, 2018-2032 (USD MILLION)
TABLE 170. CHINA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY BIOABSORBABLE POLYMER, 2018-2032 (USD MILLION)
TABLE 171. CHINA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY DRUG COATING, 2018-2032 (USD MILLION)
TABLE 172. CHINA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. CHINA IMPLANTABLE DRUG ELUTING STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Implantable Drug Eluting Stent market report include:

Abbott Laboratories
Alvimedica Medical Technologies Inc.
B. Braun Melsungen AG
Balton Sp. z o.o.
Biosensors International Group, Ltd.
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Concept Medical, Inc.
Cook Medical Incorporated
Elixir Medical Corporation
Eucatech AG
Eurocor GmbH
iVascular S.L.U.
Lepu Medical Technology (Beijing) Co., Ltd.
Medinol Ltd.
Medtronic plc
Meril Life Sciences Pvt. Ltd.
OrbusNeich Medical Group
Sahajanand Medical Technologies Ltd.
Terumo Corporation

Table Information

Report Attribute	Details
No. of Pages	191
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 4.05 Billion
Forecasted Market Value ( USD ) by 2032	$ 6.69 Billion
Compound Annual Growth Rate	8.5%
Regions Covered	Global
No. of Companies Mentioned	21

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3511EUR$3,939USD£3,045GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3787EUR$4,249USD£3,285GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5133EUR$5,759USD£4,452GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6212EUR$6,969USD£5,387GBP

Market Snapshot: Implantable Drug Eluting Stent Market Overview

Scope & Segmentation of the Implantable Drug Eluting Stent Market

Key Takeaways: Strategic Insights for Senior Decision-Makers

Tariff Impact: Implications for Cost, Sourcing, and Validation Cycles

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Implantable Coronary Drug Eluting Stent Market - Global Forecast 2026-2032

Implantable Drug Eluting Balloon Market - Global Forecast 2026-2032

Drug Eluting Stent Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

Drug-Eluting Stents Market Report ?2025-2033?

Drug Eluting Stent Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F